{
  "resourceType": "CodeSystem",
  "status": "active",
  "content": "complete",
  "name": "TumorMarkers",
  "id": "tumor-markers",
  "title": "Tumor Markers",
  "description": "Tumor markers commonly used in oncology diagnostics and monitoring in Kenya.",
  "url": "http://example.org/fhir/CodeSystem/tumor-markers",
  "concept": [
    {
      "code": "CEA",
      "display": "Carcinoembryonic Antigen"
    },
    {
      "code": "AFP",
      "display": "Alpha-fetoprotein"
    },
    {
      "code": "PSA",
      "display": "Prostate-Specific Antigen"
    },
    {
      "code": "CA125",
      "display": "Cancer Antigen 125"
    },
    {
      "code": "CA15_3",
      "display": "Cancer Antigen 15-3"
    },
    {
      "code": "CA19_9",
      "display": "Cancer Antigen 19-9"
    },
    {
      "code": "LDH",
      "display": "Lactate Dehydrogenase"
    },
    {
      "code": "hCG",
      "display": "Human Chorionic Gonadotropin"
    },
    {
      "code": "B2M",
      "display": "Beta-2 Microglobulin"
    }
  ],
  "version": "1.0.0",
  "experimental": false,
  "publisher": "Oncology Implementation Guide for Kenya",
  "caseSensitive": true,
  "count": 9
}
